Driehaus Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Driehaus Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,026	Closed	-$1.35M	–	492
2014 Q4	$1.35M	Sell	12,026 -159,581	-93%	-$14.2M	0.05%	369
2014 Q3	$10.5M	Sell	171,607 -84,654	-33%	-$3.65M	0.4%	53
2014 Q2	$11.7M	Sell	256,261 -9,898	-4%	-$403K	0.38%	50
2014 Q1	$10.4M	Buy	266,159 +12,977	+5%	+$434K	0.33%	72
2013 Q4	$6.06M	Sell	253,182 -4,789	-2%	-$109K	0.22%	143
2013 Q3	$7.21M	Buy	+257,971	New	+$7.12M	0.28%	116

Other funds holding AGIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return